Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

IGF-1 increases whisker growth in transgenic mice.

Finasteride effectively treats hair loss in transgender men with few side effects.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with high androgen levels may have more severe COVID-19 symptoms.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

PCOS may start before birth, involves metabolic issues, and can be treated with drugs like metformin and lifestyle changes.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Women with PCOS have more emotional and body image issues than healthy women.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Acne is an important sign of androgen excess disorders in women.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.